Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 28, 2025 • 6:00 PM ET

Date/Time Source News Release
05/28/2025 04:01 PM EDT Business Wire Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference
05/13/2025 04:01 PM EDT Business Wire Kezar Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update
03/25/2025 07:30 AM EDT Business Wire Kezar Life Sciences Announces Positive Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis (AIH) and Reports Fourth Quarter and Year End 2024 Financial Results
03/24/2025 08:00 AM EDT Business Wire Kezar Life Sciences to Present Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis on March 25, 2025
02/18/2025 04:01 PM EST Business Wire Kezar Life Sciences to Present at Virtual KOL Event Hosted by William Blair on Zetomipzomib Clinical Development in Autoimmune Hepatitis and Provide a Safety Update from the PALIZADE Trial for Lupus Nephritis on February 27, 2025
11/12/2024 04:01 PM EST Business Wire Kezar Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update
10/28/2024 08:30 AM EDT Business Wire Kezar Life Sciences Announces 1-for-10 Reverse Stock Split
10/17/2024 08:35 AM EDT Business Wire Kezar Board Unanimously Rejects Unsolicited Concentra Proposal and Adopts Limited Duration Stockholder Rights Plan
10/17/2024 08:30 AM EDT Business Wire Kezar Life Sciences Announces Positive IDMC Safety Review of PORTOLA Trial of Zetomipzomib in Patients with Autoimmune Hepatitis and Provides PALIZADE Update
10/10/2024 08:30 AM EDT Business Wire Kezar Confirms Receipt of Unsolicited, Non-Binding Acquisition Proposal
Page

Additional News

As of June 28, 2025 • 6:00 PM ET

Date/Time Source News Release
05/28/2025 07:26 PM EDT Stock Traders Daily When (KZR) Moves Investors should Listen
05/27/2025 12:00 PM EDT Zacks Kezar Life Sciences (KZR) Upgraded to Buy: What Does It Mean for the Stock?
05/13/2025 05:58 PM EDT SeekingAlpha Kezar Life Sciences GAAP EPS of -$2.27 beats by $0.33
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Kezar Life Sciences Inc.
05/07/2025 10:12 PM EDT Stock Traders Daily (KZR) Trading Signals
03/25/2025 06:54 PM EDT SeekingAlpha Kezar Life Sciences, Inc. (KZR) PORTOLA Topline Phase 2a Results in Autoimmune Hepatitis Conference Call (Transcript)
03/25/2025 02:57 PM EDT SeekingAlpha Kezar drops after Q4 results and mid-stage data for lead asset
03/20/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, March 20th, 2025
03/20/2025 05:30 AM EDT US Earnings Reports Expected earnings - Kezar Life Sciences Inc.
Page